Is 'Traveler's Diarrhea' Lurking in Your Backyard? The Rise of E. coli in the US
"New research reveals a surprising prevalence of Enteroaggregative E. coli (EAEC) in the US, challenging assumptions about its association with international travel and prompting a re-evaluation of food safety and public health strategies."
For years, we've associated Escherichia coli (E. coli) infections, especially those causing diarrhea, with international travel. You eat something risky on vacation, and your gut pays the price. But what if a significant source of these infections is much closer to home? Enteroaggregative E. coli (EAEC), a specific type of diarrheagenic E. coli, is now increasingly recognized as a cause of diarrheal illness, and new research suggests it's more common in the United States than previously thought.
A recent study conducted in Minnesota between 2016 and 2017 sheds light on the prevalence and characteristics of EAEC infections. What makes this study particularly interesting is its focus on understanding the domestic transmission of EAEC, challenging the conventional wisdom that it's primarily a traveler's disease. The study dives deep into the frequency of EAEC among patients with reportable enteric pathogens, analyzes the demographic profiles of those affected, and explores potential food and environmental exposures that could be contributing to its spread.
This article breaks down the key findings of this research, highlighting the surprising frequency of EAEC in the US, examining the factors that contribute to its transmission, and discussing the implications for public health and food safety. Get ready to rethink what you know about 'traveler's diarrhea' and its potential origins.
The Burden Is Easy to Miss
The CDC notes that travel-associated diarrhea caused by E. coli is likely underestimated because many travelers do not seek medical care or undergo stool testing, especially when the illness is non-bloody, as is common with enterotoxigenic E. coli (ETEC) infection. A 2024 study of travelers’ diarrhea identified ETEC colonization factors CS3 and CS21 in 25% of samples each, followed by CS2 at 18% and CS6 at 15%. Most travelers’ diarrhea cases are acute and self-limited, although the CDC reports that some people develop persistent gastrointestinal symptoms lasting more than 14 days.
Diagnosis Often Begins Clinically
A standard approach to suspected travelers’ diarrhea generally considers the timing and nature of gastrointestinal symptoms, exposure history, and whether warning signs are present. In uncomplicated cases, clinicians may use supportive care and clinical judgment rather than extensive testing, but bloody diarrhea, fever, severe abdominal pain, dehydration, or persistent symptoms can warrant further evaluation. Because presentation and causes vary, this approach can miss infections when patients do not seek care or when symptoms are mild.
The ETEC Breakthrough
Travelers’ diarrhea is commonly described as a travel-related gastrointestinal infection associated with exposure to unfamiliar food- and waterborne pathogens. A major milestone in understanding the illness was the discovery that enterotoxigenic Escherichia coli, or ETEC, can cause travelers’ diarrhea. The condition is linked to contaminated food or drinking water and may produce abdominal pain and loose stools.
EAEC: More Than Just a Traveler's Bug
The Minnesota study revealed that EAEC is surprisingly common among individuals experiencing gastrointestinal illness. In fact, within a network of healthcare systems able to detect it, EAEC emerged as the second most frequently reported enteric pathogen, surpassed only by Campylobacter. It was also the most commonly detected diarrheagenic E. coli pathotype. This high prevalence challenges the long-held assumption that EAEC is primarily an issue for international travelers.
- Foodborne Transmission: The study identified potential links between EAEC illness and the consumption of specific food items, including unpasteurized cider, cabbage, asparagus, and celery. This highlights the importance of food safety practices and the potential for contaminated produce to serve as a vehicle for EAEC transmission.
- Environmental Factors: While less conclusive, the research also explored potential environmental exposures, such as swimming. Although inverse associations were noted, additional research is needed to fully understand the role of environmental factors in EAEC transmission.
- Virulence Genes and Symptoms: The study also investigated the relationship between specific virulence genes in EAEC isolates and the severity of symptoms. Researchers identified several genes associated with outcomes such as bloody stool, hospitalization, and duration of diarrhea, offering valuable insights into the mechanisms through which EAEC causes illness.
Research Is Mapping Strains and Treatment
Recent reviews have focused on the epidemiology and causes of bacterial travelers’ diarrhea over the past decade. Foodborne pathogenic E. coli infections most commonly result from consuming contaminated food or water, and ETEC is identified as the most common cause of travelers’ diarrhea. Current research also examines ETEC and enteroaggregative E. coli strains, including their genetic diversity, virulence profiles, and possible association with persistent symptoms.
Treatment Has Important Limits
Travelers’ diarrhea is not caused exclusively by E. coli; viruses, parasites, and other bacteria may also be involved. Diagnosis is often clinical, and testing is usually unnecessary unless symptoms such as bloody diarrhea, fever, or abdominal pain are present, which can make the precise cause difficult to establish. Researchers have also warned that travelers’ diarrhea can increase the risk of acquiring multidrug-resistant organisms, while antibiotic resistance and adverse clinical outcomes have prompted calls for continued surveillance and reconsideration of treatment guidelines.
Single-Dose Therapies Compared
A clinical trial evaluated three single-dose antibiotic therapies used with loperamide for ambulatory treatment of travelers’ diarrhea. The trial found these loperamide-adjuncted regimens effective and safe, and it reported comparable effectiveness for single-dose rifaximin. The study also examined colonization with extended-spectrum beta-lactamase-producing E. coli, highlighting that treatment comparisons must be considered alongside antibiotic-resistance concerns.
What's Next? Rethinking EAEC Prevention
The Minnesota study provides compelling evidence that EAEC is a significant cause of diarrheal illness in the United States, with a substantial portion of infections acquired domestically. These findings highlight the need for a multi-pronged approach to prevent and control EAEC infections.
A Familiar Illness With Wider Stakes
The available evidence presents travelers’ diarrhea as a common gastrointestinal illness whose causes and severity vary. E. coli, particularly ETEC, is an important cause, but not every case is necessarily bacterial or suitable for antibiotics. A careful response therefore balances symptom severity, diagnostic uncertainty, treatment benefits, and the risks of unnecessary antimicrobial use.
Better Surveillance and More Targeted Care
Future progress will likely depend on improving surveillance, clarifying which strains cause persistent symptoms, and matching treatment to the likely pathogen and severity of illness. Research that combines molecular characterization with clinical outcomes may help distinguish strains with different virulence profiles. Reducing unnecessary antibiotic use while preserving effective treatment remains an important challenge.
Risk Follows Conditions and Exposure
The CDC identifies international travelers as being at increased risk for some E. coli infections, including the type that causes travelers’ diarrhea. Conditions in some countries can make it easier for E. coli to spread. Contaminated food and water are central concerns because they provide routes through which pathogenic E. coli can reach travelers.
From Sudden Illness to Operational Disruption
A New England Journal of Medicine case described a 30-year-old man who developed sudden acute watery diarrhea within 12 hours of returning from the Dominican Republic. Travelers’ diarrhea also has consequences beyond individual discomfort: a U.S. Department of Defense-funded Global Travelers’ Diarrhea study enrolled 512 participants during 2018–2023, reflecting concern about the illness among deployed U.S. military personnel and its potential to hinder operational readiness. Evidence from Thailand and Ecuador further illustrates that sanitation, food-safety practices, and local exposure patterns can shape who develops diarrheal illness and pathogenic E. coli infection.
Moving forward, it's crucial to enhance surveillance efforts to better track the prevalence and transmission patterns of EAEC in different regions of the country. This will involve improving laboratory detection methods, implementing more comprehensive reporting systems, and conducting epidemiological investigations to identify the sources of outbreaks.
Ultimately, by increasing awareness, improving food safety practices, and investing in research and surveillance, we can better protect ourselves from this increasingly common pathogen and reduce the burden of diarrheal illness in the United States.